Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announces that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & Filtration business is a leading provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications. The Solventum business operates globally with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, and has approximately 2,500 colleagues.
Read the full article: Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business //
Source: https://www.businesswire.com/news/home/20250225251876/en/Thermo-Fisher-Scientific-to-Acquire-Solventum%E2%80%99s-Purification-and-Filtration-Business